Future studies should investigate the contribution of germline mutations of BRCA1 and BRCA2 genes in a larger case-control cohort study of Brunei breast cancer population to confirm and further investigate the contribution of these germline mutations to breast cancer risk. This evidence concerns the gene BRCA2 and breast carcinoma.